Study to Evaluate the Effect of the Treatment With Micardis® or MicardisPlus® on Blood Pressure

Boehringer Ingelheim

Status: Completed

Conditions: Hypertension

Treatments: Drug: Micardis®; Drug: MicardisPlus®

Study type: Observational

Funder types: Industry

Identifiers

NCT02242864

502.506

Details and patient eligibility

About

The primary objective was to evaluate the effect of the treatment with Micardis® or MicardisPlus® on blood pressure. Secondary objectives were the effect of Micardis® / MicardisPlus® on metabolic parameters (triglycerides, cholesterol, LDL blood glucose, insulin Homeostasis Model Assessment (HOMA)-index and HbA1c) in patients with essential hypertension and diabetes mellitus

Enrollment: 1,527 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age > 18 years
• Hypertension
• Diabetes mellitus

Exclusion criteria

• Age < 18 years

Trial design

1,527 participants in 1 patient group

Patients with hypertension and diabetes mellitus

Treatment:

Drug: Micardis®

Drug: MicardisPlus®